AssayIndex
SSA cross-section

SSA by compound

SSA records split by compound, with the index-wide comparison for the same compound beside each one. 27 compounds, 219 records. Cells below n=3 print their raw values instead of a median.

27 compounds219 records
CompoundClassReportsSSA median %Index median %Δ (pp)SpecPass %
BPC-157Tissue-repair2398.1799.16-0.9998.070
SemaglutideIncretin2398.0298.89-0.8797.0100
TirzepatideIncretin2197.9798.55-0.5897.0100
RetatrutideIncretin2097.6898.37-0.6996.5100
IGF-1 DES (1-3)Growth-hormone1499.1599.12+0.0395.0100
SS-31 (Elamipretide)Metabolic1497.9799.53-1.5798.57
GHK-CuTissue-repair1398.3798.56-0.1997.0100
SemaxNeuroactive1298.6999.46-0.7798.567
MOTS-cMetabolic1298.1099.13-1.0398.058
TB-500Tissue-repair1298.5499.53-0.9998.567
PEG-MGFGrowth-hormone896.0597.75-1.7092.0100
SermorelinGrowth-hormone6 n=698.5099.06-0.5598.0100
Thymosin α1Tissue-repair6 n=698.3999.40-1.0297.5100
CJC-1295 with DACGrowth-hormone5 n=598.4198.95-0.5497.5100
Humanin (HNG)Metabolic4 n=499.0699.12-0.0697.5100
PT-141 (Bremelanotide)Melanocortin-receptor4 n=498.6599.38-0.7398.550
LL-37Tissue-repair4 n=498.1698.90-0.7596.5100
MazdutideIncretin3 n=398.8798.14+0.7396.5100
VilonShort3 n=399.1599.65-0.5099.0100
L-CarnosineShort3 n=398.9599.58-0.6399.033
GHRP-2Growth-hormone2 n=2n<399.2899.0100
5-Amino-1MQNon-peptide2 n=2n<399.4598.0100
Enclomiphene citrateNon-peptide1 n=1n<399.4498.50
L-Glutathione (reduced)Short1 n=1n<399.3398.5100
Melanotan IIMelanocortin-receptor1 n=1n<399.4298.5100
GlucagonIncretin1 n=1n<399.2098.0100
IpamorelinGrowth-hormone1 n=1n<399.4799.00
95.296.096.897.698.499.2100.0BPC-157BPC-157: Q1 97.95, median 98.17, Q3 98.45, n=23n=23SemaglutideSemaglutide: Q1 97.78, median 98.02, Q3 98.16, n=23outlier 98.94outlier 99.12n=23TirzepatideTirzepatide: Q1 97.84, median 97.97, Q3 98.27, n=21outlier 97.16outlier 99.04n=21RetatrutideRetatrutide: Q1 97.28, median 97.68, Q3 97.90, n=20n=20IGF-1 DES (1-3)IGF-1 DES (1-3): Q1 98.63, median 99.15, Q3 99.52, n=14n=14SS-31 (Elamipretide)SS-31 (Elamipretide): Q1 97.77, median 97.97, Q3 98.03, n=14outlier 97.16outlier 98.75n=14GHK-CuGHK-Cu: Q1 98.03, median 98.37, Q3 98.50, n=13n=13SemaxSemax: Q1 98.44, median 98.69, Q3 98.79, n=12outlier 97.87n=12MOTS-cMOTS-c: Q1 97.94, median 98.10, Q3 98.25, n=12outlier 98.81n=12TB-500TB-500: Q1 98.41, median 98.54, Q3 98.69, n=12outlier 99.28n=12PEG-MGFPEG-MGF: Q1 95.95, median 96.05, Q3 96.11, n=8outlier 95.57outlier 96.52n=8SermorelinSermorelin: Q1 98.38, median 98.50, Q3 98.61, n=6outlier 98.96n=6Thymosin α1Thymosin α1: Q1 98.24, median 98.39, Q3 98.65, n=6n=6CJC-1295 with DACCJC-1295 with DAC: Q1 98.39, median 98.41, Q3 99.09, n=5n=5 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.

Which of these lines SSA actually stocks

Coverage here reflects what has been submitted to the index, not what is on the catalogue. Shanghai Sigma-Audley New Material Technology Co., Ltd. lists considerably more than the 27 compounds above. Of those 27, 15 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.

Browse the SSA catalogue at shanghaisigmaaudley.com →